Fulcrum Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.89

+0.12 (+3.18%)

As of Aug 8, 10:18 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 58%

Sell 5 42%

Price Target

Analyst Price Target +1,364.8% upside

Low Target $37.54

Average Target $56.98

High Target $60.88

Current Price $3.89

Current
$3.89

Target
$56.98

$37.54 $56.98 avg $60.88

Scenario Analysis

Bear Case

$37.54

865.0%

Low target

Base Case

$56.98

+1,364.8%

Avg target

Bull Case

$60.88

+1,465.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$15.74

-75.3% from high

52-Week Low

$2.83

+37.5% from low

Target vs 52W High

$56.98

+262.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%